Mission
To significantly reduce the incidence of infectious diseases and the associated mortality rate in China and become a world-class academic center in diagnosis and treatment of infectious diseases
To significantly reduce the incidence of infectious diseases and the associated mortality rate in China and become a world-class academic center in diagnosis and treatment of infectious diseases
Founded in 2007
Director: Professor LI Lanjuan, Member of National Academy of Engineering
Space Areas: 3000+ m2
Ward Beds: 300
Research Platforms: 14
Total Value of Instruments and Equipment: 160 million Yuan
Collaborative Innovation Center: 1
Pathogenesis, prevention and treatment techniques for viral hepatitis
The diagnosis, prevention and treatment of AIDS
Infectious microecology, infectious immunology
Diagnosis and treatment of emerging and recurring infectious diseases
Number of National Science & Technology Progress Awards (2013-2017): 4
Number of National Grants (2013-2017): 150
Total Amount of Funding (2013-2017): 210 million Yuan
Number of SCI Publications (2013-2017): 500+
Number of Patents (2013-2017): 40+
Long-term Partnerships: Pasteur Institute, NIH, UCLA & the University of Hong Kong, etc.
Significant Breakthroughs:
Establishment of Artificial Liver System (Li-ALS) for treating severe liver diseases
Discovery on importance of the Gut Microbiome of Liver Cirrhosis Patients
Rapid and efficient response to emerging infectious diseases, especially H7N9 outbreak
International Recognition By: Editor from world class journal (such as Lancet); the US Department of Health; US CDC
E-mail: lilj@zju.edu.cn